Conditions: Chronic Nonmalignant and Nonneuropathic Pain
Keywords: Pain Nonmalignant pain Nonneuropathic Pain Opioid
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 922
Healthy volunteers: no

Brief summary:
The primary objective of this study is to characterize the long-term safety of Hydrocodone Bitartrate (HYD) tablets 20 to 120 mg once-daily in subjects with chronic nonmalignant and nonneuropathic pain.

Detailed description:

Arms:
arm 1: Hydrocodone bitartrate (HYD) once daily (q24h) tablets

Interventions: intervention 1: Hydrocodone bitartrate q24h film-coated tablets
Intervention descriptions: intervention 1: Hydrocodone bitartrate q24h film-coated tablets 20 - 120 mg once daily

Protocol document: